The landscape of metabolic health is changing dramatically with the emergence of several novel injectable therapies. the GLP-1/GIP dual agonist, Cagrilintide , a newer peptide, and a GLP-1 receptor agonist https://nexaphresearchpeptides.com/product-category/cosmetic-peptides/